Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Claudio Mencacci,1 Guido Di Sciascio,2 Pablo Katz,3 Claudio Ripellino31Ospedale Fatebenefratelli, Milan, Italy; 2Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy; 3CSD Medical Research Srl, Milan, ItalyBackground: Depression has a lifetime prevalence of 10%&ndas...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Mencacci C, Di Sciascio G, Katz P, Ripellino C
Format: Artikel
Sprache:English
Veröffentlicht: Dove Medical Press 2013-02-01
Schriftenreihe:ClinicoEconomics and Outcomes Research
Online Zugang:http://www.dovepress.com/cost-effectiveness-evaluation-of-escitalopram-in-major-depressive-diso-a12150